Omega Therapeutics Stock Price on November 1, 2024
| OMGA Stock | USD 0.86 0.07 8.86% |
If you're considering investing in Omega Stock, it is important to understand the factors that can impact its price. As of today, the current price of Omega Therapeutics stands at 0.86, as last reported on the 26th of November, with the highest price reaching 0.88 and the lowest price hitting 0.78 during the day. Omega Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0928, which implies the firm had a -0.0928% return per unit of risk over the last 3 months. Omega Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Omega Therapeutics' Coefficient Of Variation of (807.22), risk adjusted performance of (0.09), and Variance of 41.06 to confirm the risk estimate we provide.
At present, Omega Therapeutics' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 86.5 M, whereas Common Stock Total Equity is forecasted to decline to about 29.1 K. . At present, Omega Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.11, whereas Price To Sales Ratio is forecasted to decline to 49.92. Omega Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Omega |
Sharpe Ratio = -0.0928
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OMGA |
Estimated Market Risk
| 6.65 actual daily | 59 59% of assets are less volatile |
Expected Return
| -0.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Omega Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Omega Therapeutics by adding Omega Therapeutics to a well-diversified portfolio.
Price Book 3.7701 | Enterprise Value Ebitda (2.12) | Price Sales 6.8923 | Shares Float 21.3 M | Wall Street Target Price 9.5 |
Related Headline
Larimar Therapeutics Headline on 1st of November 2024
Larimar Therapeutics Posts Quarterly Earnings Results by thelincolnianonline.com
Larimar Therapeutics posted its quarterly earnings data on Wednesday. The company reported earnings per share for the quarter, beating the consensus estimate of by 0.13, RTT News reports. During the same quarter in the prior year, the firm earned earnings per share. Larimar Therapeutics Stock Down
Omega Therapeutics Valuation on November 1, 2024
It is possible to determine the worth of Omega Therapeutics on a given historical date. On November 1, 2024 Omega was worth 1.17 at the beginning of the trading date compared to the closed value of 1.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Omega Therapeutics stock. Still, in general, we apply an absolute valuation method to find Omega Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Omega Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Omega Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.26 | 1.30 | 1.15 | 1.16 | 329,174 | |
11/01/2024 | 1.17 | 1.22 | 1.10 | 1.11 | 245,322 |
| 1.11 | 1.12 | 1.04 | 1.04 | 234,718 |
| Backtest Omega Therapeutics | | | Omega Therapeutics History | | | Omega Therapeutics Valuation | Previous | Next |
Omega Therapeutics Trading Date Momentum on November 1, 2024
| On November 04 2024 Omega Therapeutics was traded for 1.04 at the closing time. The top price for the day was 1.12 and the lowest listed price was 1.04 . The trading volume for the day was 234.7 K. The trading history from November 4, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 6.31% . The trading delta at closing time against the current closing price is 1.80% . |
Omega Therapeutics Fundamentals Correlations and Trends
By evaluating Omega Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Omega Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Omega financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Omega Therapeutics Stock history
Omega Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Omega is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Omega Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Omega Therapeutics stock prices may prove useful in developing a viable investing in Omega Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 54 M | 54 M | |
| Net Loss | -92.4 M | -87.8 M |
Omega Therapeutics Quarterly Net Working Capital |
|
Omega Therapeutics Stock Technical Analysis
Omega Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Omega Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Omega Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Omega Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Omega Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Omega Therapeutics shares will generate the highest return on investment. By undertsting and applying Omega Therapeutics stock market strength indicators, traders can identify Omega Therapeutics entry and exit signals to maximize returns
Omega Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Omega Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Omega Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Omega to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.02) | |||
| Total Risk Alpha | (1.81) | |||
| Treynor Ratio | (0.46) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Omega Stock analysis
When running Omega Therapeutics' price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |